Literature DB >> 1910173

Molecular dynamics of dopamine at the D2 receptor.

S G Dahl1, O Edvardsen, I Sylte.   

Abstract

A three-dimensional model of the dopamine D2 receptor, assumed to be a target of antipsychotic drug action, was constructed from its amino acid sequence. The model was based on structural similarities within the super-family of guanine nucleotide-binding regulatory (G) protein-coupled neuroreceptors and has seven alpha-helical transmembrane segments that form a central core with a putative ligand-binding site. The space between two residues postulated to be involved in agonist binding, Asp-80 and Asn-390, perfectly accommodated an anti-dopamine molecule. Molecular electrostatic potentials were mainly negative on the synaptic side of the receptor model and around aspartate residues lining the central core and positive in the cytoplasmic domains. The docking of dopamine into a postulated binding site was examined by molecular dynamics simulation. The protonated amino group became oriented toward negatively charged aspartate residues in helix 2 and helix 3, whereas the dopamine molecule fluctuated rapidly between different anti and gauche conformations during the simulation. The receptor model suggests that protonated ligands are attracted to the binding site by electrostatic forces and that protonated agonists may induce conformational changes in the receptor, leading to G-protein activation, by increasing the electrostatic potentials near Asp-80.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910173      PMCID: PMC52456          DOI: 10.1073/pnas.88.18.8111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Fine-tuning the topology of a polytopic membrane protein: role of positively and negatively charged amino acids.

Authors:  I Nilsson; G von Heijne
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

2.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

Authors:  R K Sunahara; H C Guan; B F O'Dowd; P Seeman; L G Laurier; G Ng; S R George; J Torchia; H H Van Tol; H B Niznik
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

3.  Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Authors:  C A Altar; W C Boyar; A Wasley; S C Gerhardt; J M Liebman; P L Wood
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

4.  D2 receptor, a missing exon.

Authors:  K A Eidne; P L Taylor; J Zabavnik; P T Saunders; J D Inglis
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

5.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

Authors:  B Giros; P Sokoloff; M P Martres; J F Riou; L J Emorine; J C Schwartz
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

6.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

Authors:  H Y Meltzer; S Matsubara; J C Lee
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

7.  Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor.

Authors:  T Kubo; K Fukuda; A Mikami; A Maeda; H Takahashi; M Mishina; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

8.  Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.

Authors:  D Julius; A B MacDermott; R Axel; T M Jessell
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

9.  Protein secondary structure and homology by neural networks. The alpha-helices in rhodopsin.

Authors:  H Bohr; J Bohr; S Brunak; R M Cotterill; B Lautrup; L Nørskov; O H Olsen; S B Petersen
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

10.  Identification of residues required for ligand binding to the beta-adrenergic receptor.

Authors:  C D Strader; I S Sigal; R B Register; M R Candelore; E Rands; R A Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more
  12 in total

1.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  A sequence and structural study of transmembrane helices.

Authors:  R P Bywater; D Thomas; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

3.  On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors.

Authors:  L Pardo; J A Ballesteros; R Osman; H Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 4.  Functional domains of the gonadotropin-releasing hormone receptor.

Authors:  S C Sealfon; R P Millar
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

5.  BUNDLE: a program for building the transmembrane domains of G-protein-coupled receptors.

Authors:  M Filizola; J J Perez; M Cartenì-Farina
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

6.  Dynamic modelling of the binding of substances to the conserved membrane-adjacent heptapeptide of the 15-residue C-terminal cytoplasmic fragment of mammalian dopamine D2 receptors.

Authors:  E Roberts; J Wendel
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

7.  Automated method for modeling seven-helix transmembrane receptors from experimental data.

Authors:  P Herzyk; R E Hubbard
Journal:  Biophys J       Date:  1995-12       Impact factor: 4.033

8.  Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor.

Authors:  A O Colson; J H Perlman; A Smolyar; M C Gershengorn; R Osman
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

9.  Structural changes by sulfoxidation of phenothiazine drugs.

Authors:  S G Dahl; P A Kollman; S N Rao; U C Singh
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

Review 10.  Pharmacokinetics and pharmacodynamics of clozapine.

Authors:  M W Jann; S R Grimsley; E C Gray; W H Chang
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.